Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PaLaDIn

Financiado

Cerrado

Patient Lifestyle and Disease Data Interactium

Neuromuscular disease is at the forefront of collecting real-world demographic and clinically-relevant data from patients.PaLaDIn, a public private partnership, will leverage TREAT-NMD's Global Registry Platform. This uses patient... ver más

31/12/2027

PARENT PROJECT APS

19M€

Presupuesto del proyecto: 19M€

Líder del proyecto

PARENT PROJECT APS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-01

HORIZON-JU-IHI-2022-03-02: Patient-generated evidence to impro... ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topi...

I+D

Cerrada

0% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

PARENT PROJECT APS

Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 47 meses Fecha Inicio: 2024-01-01
Fecha Fin: 2027-12-31

Líder del proyecto

PARENT PROJECT APS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 19M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Neuromuscular disease is at the forefront of collecting real-world demographic and clinically-relevant data from patients.PaLaDIn, a public private partnership, will leverage TREAT-NMD's Global Registry Platform. This uses patient data to support clinical trial planning/recruitment as well as more complex regulator-driven studies. With other Partners’ expertise in patient engagement and FAIR data, this a public private partnership, will develop the Interactium, a new, integrated approach to patient data.The Interactium will align registry-reported data with Patient Reported Outcome/Experience Measures and other data e.g., wearables and Internet of Things devices, and share the collated, holistic data to improve outcomes and decision-making, and accelerate innovation for a range of stakeholders (patients, regulators, industry and initiatives like DARWIN).PaLaDIn’s other objectives:•Develop a patient interface to collect patient preferences to support an inclusive approach, and to allow visualization of data and control over its use.•Provide class-leading tools to support all stages of decision-making in translational research, care and diagnosis across the neuromuscular field and develop Standard Operating Procedures to allow utilization across the rare disease and wider health fields.•To provide communications and shared learning outside the neuromuscular disease field to support scale-up development of similar systems and capabilities across all diseases.Developing a patient-centric and cost-effective advanced integrated healthcare solution requires well defined patient groups in significant, but manageable numbers, extensive ongoing research and trials and drugs at all stages of development. Neuromuscular diseases provides all of these; however, the Interactium and associated processes and frameworks have much wider potential. A system that can ingest data from any relevant source, align that data at patient level, and provide data analysis to support decision-making by patients, clinicians, regulators and health-related industries is equally relevant to more common diseases such as diabetes.PaLaDIn key deliverables•Flexible Interactium omni data platform•Architecture/template for an improved user experience•Architecture for wearable infrastructure•Novel methods for FAIRification process•Toolkit for rare disease patient organisations

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores